News

Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer

–Dr. von Moltke brings over 30 years of deep drug development experience and a proven track record of clinical and…

9 months ago

Kraig Biocraft Laboratories Confirms Operations in Vietnam’s Silk Production Hub, Lam Dong Province

ANN ARBOR, Mich., March 17, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a…

9 months ago

Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS

sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved,…

9 months ago

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry…

9 months ago

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test AccuracyMISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE…

9 months ago

Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

DeepView® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history,…

9 months ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

       – Gino Santini Appointed as Chairman of the Board, Michael Heffernan, Founder and Chairman and Gwen A. Melincoff, Board…

9 months ago

Restart Life Expands Intellectual Property Through Trademark Licensing Agreement

Vancouver, British Columbia--(Newsfile Corp. - March 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD)…

9 months ago

Neural Therapeutics Commences Trading, Provides Update on Growth Initiatives and Engages Investor Relations Consultants

Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - Neural Therapeutics Inc. (CSE: NURL) ("Neural" or the "Company"), an ethnobotanical drug…

9 months ago

Fangzhou Inc.’s H2H Smart Healthcare Platform Honored as one of Guangdong’s Premier High-Tech Innovation Products

GUANGZHOU, China, March 17, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions,…

9 months ago